Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

NCT07430501 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 7720

Last updated 2026-02-24

No results posted yet for this study

Summary

The goal of this observational study is to create a detailed virtual model to better understand how Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) develops. This model will also help predict heart problem at different stage of the disease.

Conditions

  • Metabolic Dysfunction-Associated Steatotic Liver Disease

Interventions

OTHER

Data recollection

Only data recollection for their use in the training, testing and early validation of computational models (but no other intervention) will be performed.

Sponsors & Collaborators

  • Matical Innovation SL

    collaborator UNKNOWN
  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER
  • Jena University Hospital

    collaborator OTHER
  • Institut National de Recherche en Informatique et Automatique

    collaborator UNKNOWN
  • German Cancer Research Center

    collaborator OTHER
  • MEDEX

    collaborator OTHER
  • EUROPEAN LIVER PATIENTS ASSOCIATION

    collaborator UNKNOWN
  • Betthera s.r.o.

    collaborator OTHER
  • Bournemouth University

    collaborator OTHER
  • University Hospital Heidelberg

    collaborator OTHER
  • Fundacion Para La Investigacion Hospital La Fe

    collaborator OTHER
  • University of Roma La Sapienza

    collaborator OTHER
  • Charite University, Berlin, Germany

    collaborator OTHER
  • Medical University of Vienna

    collaborator OTHER
  • Saint-Luc University Hospital

    collaborator UNKNOWN
  • University of Freiburg

    collaborator OTHER
  • University of Leipzig

    collaborator OTHER
  • Sheba Medical Center

    collaborator OTHER_GOV
  • Imperial College London

    collaborator OTHER
  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-02-23
Primary Completion
2026-06-02
Completion
2027-09-02

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07430501 on ClinicalTrials.gov